Championing the missions that matter™. From development to delivery, we help pharma, biotech & consumer health companies transform lives.

Tampa
Joined March 2010
Attending #CHARM2026 tomorrow? Watch our on-demand webinar ahead of it to explore how CMC strategies are evolving across autologous, allogeneic, iPSC, and in vivo cell therapies. Book a meeting to continue the conversation at CHARM: ow.ly/BnR05101gYB #CellTherapy #CMC
61
Join Catalent’s Yuichi Kamiya, Regional Sales Director, Asia, at BIOPLUS-INTERPHEX KOREA 2026. 📍 COEX Seoul, Conference Room 317 📅 Friday, October 30 🕚 11:10–11:40 a.m. Book a meeting: ow.ly/r0nI51014Hr #BIOPLUSINTERPHEXKOREA #BIX2026 #DrugDelivery #OralDrugDelivery
71
Planning a study across China and Asia-Pacific? Meet our clinical supply team at the #ChinaTrials 18 to explore how our global capabilities can support your studies. Find us at Booth 5! Book a meeting with us: catalent.com/events/china-tr… #ClinicalDevelopment #ClinicalSupply
66
That’s a wrap on AusBiotech 2026! Thank you to everyone who connected with the Catalent team and shared insights on the innovations, challenges & opportunities shaping the future of biotechnology. #AusBiotech2026 #Biotechnology #Biopharma #DrugDevelopment #PharmaInnovation
100
Now available on-demand, this webinar explores how developers can proactively adapt to global regulatory expectations and build a stronger foundation for approval and patient access. Watch here: ow.ly/Z9Iq5100rmx #CellTherapy #AdvancedTherapies #Biologics
82
Catalent is heading to the 4th Annual CHARM Cell & Gene Therapy Symposium in Washington. Don’t miss John Tomtishen, Global Head Cell Therapy at Catalent, as he presents on October 28! Book a meeting with our experts: ow.ly/83Bs5100rhX #CellAndGeneTherapy #CHARM2026
86
In our executive summary, we explore best practices for navigating regulatory requirements, reducing supply risk and strengthening comparator sourcing strategies through integrated models and emerging technologies. Read now: ow.ly/zjP151001en #ClinicalSupply #Supplychain
1
83
With AAV continuing to play a critical role in gene therapy, Catalent’s on-demand webinar explores strategies for navigating manufacturing complexity and building scalable, future-ready AAV programs. Watch on-demand: ow.ly/MX1B50ZZOcX #AAV #GeneTherapy #CGT
1
116
Join Catalent for “From Molecule to Milestone: Building and Funding the Path to the Clinic”. From early development toward clinical readiness. Register today: ow.ly/XzRG50ZZkxc #DrugDevelopment #EarlyPhaseDevelopment #BiotechFunding #ClinicalDevelopment #PharmaInnovation
113
Attending ChinaTrials 18? Come find us at Booth #5 in Shanghai, October 28–30. We’d love to hear what you’re working on and see if our comprehensive clinical supply services that can help support your studies. Book a 1:1 with us: ow.ly/pJem50ZZifA #ClinicalTrials
81
Meet Catalent at #BioplusInterphexKorea! From drug development & clinical supply to commercial capabilities, our team is here to support your product’s journey from early discovery through market launch. Book a meeting with us: ow.ly/F3gM50ZYXvH #CDMO #DrugDevelopment
116
Catalent is heading to #AAPS2026! Visit us at Booth #1811 to explore how our scientific expertise can help tackle complex challenges across formulation, drug delivery, scale-up, and commercialization. Connect with the team: ow.ly/5icx50ZYY6r #PharmSci360 #DrugDelivery
78
Attending the 2026 AusBiotech International Conference? Come meet the APAC team to learn about our flexible, comprehensive clinical supply services and how we can help support your studies. Book a meeting with us: ow.ly/2WTS50ZYX0N #ClinicalTrials #ClinicalSupply
83
The insights from #GCSG2026 don’t have to end in Rome. Explore how a more strategic approach to QP oversight can help keep clinical trials on track in our executive summary. Download now: ow.ly/6IUH50ZYQSP #ClinicalTrials #ClinicalSupply #ClinicalSupply
106
Explore how a phase-appropriate strategy resolves DAR distribution, linker stability, and aggregation risk early enough to guide development from discovery through commercialization. Download the article: ow.ly/AtA950ZYmv0
101
In a recent @biospace article, Catalent’s Laura Daley, shares her insights on how CDMOs are evolving to support increasingly sophisticated modalities, from precise expression balancing & deeper characterization to flexible downstream strategies. Read now: ow.ly/k3IO50ZXVgi
1
1
94
Innovation was on full display at the recent 2026 #Endpoints11 Awards as biotechnology's rising stars were recognized for their vision, scientific excellence and commitment to advancing patient outcomes. Access the recording here: ow.ly/zKw250ZXZL8 #BiotechInnovation
76